Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Personalized genomic interventions can effectively manage chronic hair loss.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Exosomes could improve skin health and treat skin diseases, but more research is needed.

Gene and cell therapies are being developed to treat rare skin conditions like epidermolysis bullosa and ichthyosis.

The new treatment effectively heals drug-resistant bacteria-infected wounds.

Thyroid receptor β can help develop new drugs to treat hair loss.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Exosomes from special stem cells help treat ulcerative colitis by reducing inflammation and stress.

New treatments for androgenetic alopecia show promise but need more research for validation.

Targeted cancer therapies can cause skin side effects, but activating SOS in the skin may help reduce them.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Microneedles can precisely deliver cancer treatments with fewer side effects.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

Blocking certain immune signals can reduce skin damage from radiation therapy.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Understanding snoRNA regulation may help slow skin aging.

MicroRNAs are important for skin development and diseases and could be used for treatment and diagnosis.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

A new engineered treatment shows promise in curing heart fibrosis.

Researchers fixed gene mutations causing a skin disease in stem cells, which then improved skin grafts in mice.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Finasteride may help treat childhood brain tumors by activating certain genes.

Blocking specific proteins can help remove aging cells and might treat age-related diseases and promote hair growth.